icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
Virtual
February 12-16, 2022
Back grey_arrow_rt.gif
 
 
 
HCV MICROELIMINATION AMONG PEOPLE LIVING
WITH HIV IN SAN DIEGO: ARE WE ON TRACK?
 
 
  CROI 2022 Feb 11-16
 
The model is parameterized using the San Diego County 2018 HCV seroprevalence estimates of 65.6%, 4.6%, and 16.5% among PWID, MSM, and MSM with HIV, respectively. Additionally, we calibrated HCV viremia prevalence among PLWH of 30.9% (2013) and 18.5% (2018) based on the UCSD Owen Clinic data.
 
Jaskaran S Cheema1, William C Mathews1, Adriane Wynn1, Laura P Bamford1, Francesca J Torriani1, Lucas A Hill1, Amutha V Rajagopal1, Jeffrey Yin1, Cachay R. Edward1* and Natasha K Martin1*
1University of California San Diego, La Jolla, CA *Contributed equally

0220221

0220222

0220223

0220224

0220225